Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Oral baricitinib is effective and safe for treating alopecia areata.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Anethole reduces inflammation and oxidative stress in colitis.

A20 protein is crucial for normal skin and hair development.

Eclipta alba may help with antiaging by improving mitochondrial function.

CCCA causes progressive hair loss in Black women, starting from a central scalp patch.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Acupuncture and herbal treatments effectively reduced hair loss in androgenetic alopecia.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

Aloe vera in hair products promotes healthy, strong hair but may cause allergies in some people.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Using these leaves to wrap corn-based foods in Togo is safe and boosts nutrition and preservation.

A peptide from fermented Trapa japonica fruit may help reduce skin aging.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Baricitinib successfully treated severe hair loss.

Tofacitinib may help regrow hair in alopecia areata patients.

Women with hair loss may have higher heart disease risk.

Amalaki Churna effectively reduces hair fall and improves hair health.

Apremilast did not work for treating severe alopecia areata.

Genetic factors, especially PADI3 gene variants, contribute to CCCA in women of African descent.